Cloxacillin
General information:
| Withdrawn ID: | 986 |
|---|---|
| Canonical SMILES: | |
| Standard InChI: | |
| Standard InChIKey: | |
| ATC class(es): | J01CF02 |
| Molecular Formula: | C19H18ClN3O5S |
| Molweight: | 435.881 |
Withdrawal information:
| Withdrawn due to drug safety reasons: | No |
|---|---|
| First approved: | 1974 |
Side-effects:
| Total reported cases (submitted by medical professionals) with Cloxacillin as primary suspect: | 5 |
|---|
Reported final outcomes:
| Hospitalization (initial or prolonged): | 3 |
|---|
Reported side-effects:
| Side-effect | Case number |
|---|---|
| WHITE BLOOD CELL COUNT INCREASED | 1 |
| TOXIC SKIN ERUPTION | 1 |
| Renal failure | 1 |
| Multiple sclerosis relapse | 1 |
| Jaundice | 1 |
| Hepatitis cholestatic | 1 |
| Gamma-glutamyltransferase increased | 1 |
| Endocarditis candida | 1 |
| Duodenal stenosis | 1 |
| Drug reaction with eosinophilia and systemic symptoms | 1 |
| DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS | 1 |
| Dizziness | 1 |
| Cholestasis | 1 |
| Blood bilirubin increased | 1 |
| Blood alkaline phosphatase increased | 1 |
| Aspartate aminotransferase increased | 1 |
Toxicity information:
| Toxicity class: | 5 |
|---|---|
| Toxicity type: | N/A |
| LD50: | 3800 mg/kg |
External links:
| ChEBML: | CHEMBL891 |
|---|---|
| DrugBank: | DB01147 |